These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11282107)

  • 41. Paramyotonia congenita mutations reveal different roles for segments S3 and S4 of domain D4 in hSkM1 sodium channel gating.
    Ji S; George AL; Horn R; Barchi RL
    J Gen Physiol; 1996 Feb; 107(2):183-94. PubMed ID: 8833340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cold-induced disruption of Na+ channel slow inactivation underlies paralysis in highly thermosensitive paramyotonia.
    Carle T; Fournier E; Sternberg D; Fontaine B; Tabti N
    J Physiol; 2009 Apr; 587(Pt 8):1705-14. PubMed ID: 19221125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Muscle sodium channel inactivation defect in paramyotonia congenita with the thr1313met mutation.
    Tahmoush AJ; Schaller KL; Zhang P; Hyslop T; Heiman-Patterson T; Caldwell JH
    Neuromuscul Disord; 1994; 4(5-6):447-54. PubMed ID: 7533571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence.
    Mohammadi B; Jurkat-Rott K; Alekov A; Dengler R; Bufler J; Lehmann-Horn F
    Pharmacogenet Genomics; 2005 Apr; 15(4):235-44. PubMed ID: 15864116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lidocaine induces a slow inactivated state in rat skeletal muscle sodium channels.
    Chen Z; Ong BH; Kambouris NG; Marbán E; Tomaselli GF; Balser JR
    J Physiol; 2000 Apr; 524 Pt 1(Pt 1):37-49. PubMed ID: 10747182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-channel analysis of inactivation-defective rat skeletal muscle sodium channels containing the F1304Q mutation.
    Lawrence JH; Orias DW; Balser JR; Nuss HB; Tomaselli GF; O'Rourke B; Marban E
    Biophys J; 1996 Sep; 71(3):1285-94. PubMed ID: 8874003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A gating model for wildtype and R1448H Nav1.4 channels in paramyotonia.
    Holzherr B; Lehmann-Horn F; Kuzmenkina E; Fan C; Jurkat-Rott K
    Acta Myol; 2014 May; 33(1):22-33. PubMed ID: 24843232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit.
    Makita N; Shirai N; Wang DW; Sasaki K; George AL; Kanno M; Kitabatake A
    Circulation; 2000 Jan 4-11; 101(1):54-60. PubMed ID: 10618304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia.
    Desaphy JF; Camerino DC; Tortorella V; De Luca A
    Neuromuscul Disord; 1999 May; 9(3):182-9. PubMed ID: 10382914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro.
    Yang N; Ji S; Zhou M; Ptácek LJ; Barchi RL; Horn R; George AL
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12785-9. PubMed ID: 7809121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced slow inactivation by V445M: a sodium channel mutation associated with myotonia.
    Takahashi MP; Cannon SC
    Biophys J; 1999 Feb; 76(2):861-8. PubMed ID: 9929487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
    Sheets MF; Hanck DA
    J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels.
    Balser JR; Nuss HB; Orias DW; Johns DC; Marban E; Tomaselli GF; Lawrence JH
    J Clin Invest; 1996 Dec; 98(12):2874-86. PubMed ID: 8981936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of a new sodium channel mutation at arginine 1448 associated with moderate Paramyotonia congenita in humans.
    Bendahhou S; Cummins TR; Kwiecinski H; Waxman SG; Ptácek LJ
    J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):337-44. PubMed ID: 10381583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quaternary ammonium block of mutant Na+ channels lacking inactivation: features of a transition-intermediate mechanism.
    Kimbrough JT; Gingrich KJ
    J Physiol; 2000 Nov; 529 Pt 1(Pt 1):93-106. PubMed ID: 11080254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time-dependent block and resurgent tail currents induced by mouse beta4(154-167) peptide in cardiac Na+ channels.
    Wang GK; Edrich T; Wang SY
    J Gen Physiol; 2006 Mar; 127(3):277-89. PubMed ID: 16505148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis.
    Cannon SC; Corey DP
    J Physiol; 1993 Jul; 466():501-20. PubMed ID: 8105077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paramyotonia congenita: the R1448P Na+ channel mutation in adult human skeletal muscle.
    Lerche H; Mitrovic N; Dubowitz V; Lehmann-Horn F
    Ann Neurol; 1996 May; 39(5):599-608. PubMed ID: 8619545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome.
    Abriel H; Wehrens XH; Benhorin J; Kerem B; Kass RS
    Circulation; 2000 Aug; 102(8):921-5. PubMed ID: 10952963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of slow inactivation in human heart and rat skeletal muscle Na+ channel chimaeras.
    O'Reilly JP; Wang SY; Kallen RG; Wang GK
    J Physiol; 1999 Feb; 515 ( Pt 1)(Pt 1):61-73. PubMed ID: 9925878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.